Corbus Pharmaceuticals (CRBP)
(Delayed Data from NSDQ)
$19.51 USD
-32.19 (-62.26%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $20.08 +0.57 (2.92%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CRBP 19.51 -32.19(-62.26%)
Will CRBP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CRBP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRBP
Wall Street Analysts Think Corbus Pharmaceuticals (CRBP) Could Surge 43.82%: Read This Before Placing a Bet
Corbus Pharmaceuticals (CRBP) Upgraded to Buy: Here's Why
CRBP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Corbus Pharmaceuticals (CRBP) Could Rally 54.24%: Here's is How to Trade
Here's What Could Help Corbus Pharmaceuticals (CRBP) Maintain Its Recent Price Strength
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
Other News for CRBP
Corbus Pharma plunges 60% following Novo Nordisk weight loss drug data
Cannabis Stock Movers For September 20, 2024
Corbus sinks 61% to $20 after Novo Nordisk weight loss data
Corbus price target lowered to $51 from $85 at Wedbush after Novo data
Skye Bioscience, Corbus sink after Novo weight loss data